Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 421 entries
Sorted by: Best Match Show Resources per page
In Vitro activity of daptomycin against MRSA and vancomycin hetero-resistant MRSA (h-MRSA) isolated from patients at Siraj hospital

community settings

[No authors listed]
GSID: y4A06q7qmoEJ
S Trakulsomboom, V Thamlikitkul - J. Infect. Dis. Antimicrob. Agents, 2008

No abstract available.

Cite
Trakulsomboom, S., & Thamlikitkul, V. (2008). In Vitro activity of daptomycin against MRSA and vancomycin hetero-resistant MRSA (h-MRSA) isolated from patients at Siraj hospital. J. Infect. Dis. Antimicrob. Agents, 25(1), 57-61.
Trakulsomboom, S., and V. Thamlikitkul. "In Vitro activity of daptomycin against MRSA and vancomycin hetero-resistant MRSA (h-MRSA) isolated from patients at Siraj hospital." J. Infect. Dis. Antimicrob. Agents 25.1 (2008): 57-61.
Copy Download .nbib Format: MLA
Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus.

Antimicrobial resistance and infection control

Storm JC, Diekema DJ, Kroeger JS, Johnson SJ, Johannsson B.
PMID: 22958379
Antimicrob Resist Infect Control. 2012 May 29;1(1):19. doi: 10.1186/2047-2994-1-19.

BACKGROUND: Daptomycin non-susceptible enterococci (DNSE) are emerging as an important cause of healthcare-associated infection, however little is known about the epidemiology of DNSE. At the University of Iowa Hospitals and Clinics (UIHC) an increase in the frequency of patients...

Cite
Storm JC, Diekema DJ, Kroeger JS, et al. Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus. Antimicrob Resist Infect Control. 2012;1(1):19doi: 10.1186/2047-2994-1-19.
Storm, J. C., Diekema, D. J., Kroeger, J. S., Johnson, S. J., & Johannsson, B. (2012). Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus. Antimicrobial resistance and infection control, 1(1), 19. https://doi.org/10.1186/2047-2994-1-19
Storm, Jeremy C, et al. "Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus." Antimicrobial resistance and infection control vol. 1,1 (2012): 19. doi: https://doi.org/10.1186/2047-2994-1-19
Storm JC, Diekema DJ, Kroeger JS, Johnson SJ, Johannsson B. Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus. Antimicrob Resist Infect Control. 2012 May 29;1(1):19. doi: 10.1186/2047-2994-1-19. PMID: 22958379; PMCID: PMC3436660.
Copy Download .nbib Format: NLM
Current microbiology of surgical site infections associated with breast cancer surgery .

Wounds : a compendium of clinical research and practice

Rolston K, Mihu C, Tarrand J.
PMID: 25902178
Wounds. 2010 May;22(5):132-5.

 Surgical site infections (SSI) are the most common complications of breast cancer surgery. The authors identified 35 cases of SSI in the M.D. Anderson Cancer Center (Houston, TX) over a 7-month study period. Monomicrobial infections predominated (69%) with...

Cite
Rolston K, Mihu C, Tarrand J. Current microbiology of surgical site infections associated with breast cancer surgery . Wounds. 2010;22(5):132-5
Rolston, K., Mihu, C., & Tarrand, J. (2010). Current microbiology of surgical site infections associated with breast cancer surgery . Wounds : a compendium of clinical research and practice, 22(5), 132-5.
Rolston, Kenneth, et al. "Current microbiology of surgical site infections associated with breast cancer surgery ." Wounds : a compendium of clinical research and practice vol. 22,5 (2010): 132-5.
Rolston K, Mihu C, Tarrand J. Current microbiology of surgical site infections associated with breast cancer surgery . Wounds. 2010 May;22(5):132-5. PMID: 25902178.
Copy Download .nbib Format: NLM
Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis.

Therapeutics and clinical risk management

Liu C, Mao Z, Yang M, Kang H, Liu H, Pan L, Hu J, Luo J, Zhou F.
PMID: 27703367
Ther Clin Risk Manag. 2016 Sep 22;12:1455-1466. doi: 10.2147/TCRM.S115175. eCollection 2016.

BACKGROUND: Skin and soft tissue infections (SSTIs) are significant indications for antibiotic treatment. Daptomycin, a novel antibiotic, has been registered and licensed to be used in the treatment of these infections. However, its efficacy and safety remain controversial.OBJECTIVE: The...

Cite
Liu C, Mao Z, Yang M, et al. Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis. Ther Clin Risk Manag. 2016;12:1455-1466doi: 10.2147/TCRM.S115175.
Liu, C., Mao, Z., Yang, M., Kang, H., Liu, H., Pan, L., Hu, J., Luo, J., & Zhou, F. (2016). Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis. Therapeutics and clinical risk management, 121455-1466. https://doi.org/10.2147/TCRM.S115175
Liu, Chao, et al. "Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis." Therapeutics and clinical risk management vol. 12 (2016): 1455-1466. doi: https://doi.org/10.2147/TCRM.S115175
Liu C, Mao Z, Yang M, Kang H, Liu H, Pan L, Hu J, Luo J, Zhou F. Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis. Ther Clin Risk Manag. 2016 Sep 22;12:1455-1466. doi: 10.2147/TCRM.S115175. eCollection 2016. PMID: 27703367; PMCID: PMC5038576.
Copy Download .nbib Format: NLM
A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library.

Frontiers in microbiology

Feng J, Shi W, Zhang S, Sullivan D, Auwaerter PG, Zhang Y.
PMID: 27242757
Front Microbiol. 2016 May 23;7:743. doi: 10.3389/fmicb.2016.00743. eCollection 2016.

Although currently recommended antibiotics for Lyme disease such as doxycycline or amoxicillin cure the majority of the patients, about 10-20% of patients treated for Lyme disease may experience lingering symptoms including fatigue, pain, or joint and muscle aches. Under...

Cite
Feng J, Shi W, Zhang S, et al. A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library. Front Microbiol. 2016;7:743doi: 10.3389/fmicb.2016.00743.
Feng, J., Shi, W., Zhang, S., Sullivan, D., Auwaerter, P. G., & Zhang, Y. (2016). A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library. Frontiers in microbiology, 7743. https://doi.org/10.3389/fmicb.2016.00743
Feng, Jie, et al. "A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library." Frontiers in microbiology vol. 7 (2016): 743. doi: https://doi.org/10.3389/fmicb.2016.00743
Feng J, Shi W, Zhang S, Sullivan D, Auwaerter PG, Zhang Y. A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library. Front Microbiol. 2016 May 23;7:743. doi: 10.3389/fmicb.2016.00743. eCollection 2016. PMID: 27242757; PMCID: PMC4876775.
Copy Download .nbib Format: NLM
Daptomycin-induced eosinophilic pneumonia.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Roux S, Ferry T, Chidiac C, Valour F.
PMID: 26117342
Int J Infect Dis. 2015 Aug;37:95-6. doi: 10.1016/j.ijid.2015.06.010. Epub 2015 Jun 24.

No abstract available.

Cite
Roux S, Ferry T, Chidiac C, et al. Daptomycin-induced eosinophilic pneumonia. Int J Infect Dis. 2015;37:95-6doi: 10.1016/j.ijid.2015.06.010.
Roux, S., Ferry, T., Chidiac, C., & Valour, F. (2015). Daptomycin-induced eosinophilic pneumonia. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 3795-6. https://doi.org/10.1016/j.ijid.2015.06.010
Roux, Sandrine, et al. "Daptomycin-induced eosinophilic pneumonia." International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases vol. 37 (2015): 95-6. doi: https://doi.org/10.1016/j.ijid.2015.06.010
Roux S, Ferry T, Chidiac C, Valour F. Daptomycin-induced eosinophilic pneumonia. Int J Infect Dis. 2015 Aug;37:95-6. doi: 10.1016/j.ijid.2015.06.010. Epub 2015 Jun 24. PMID: 26117342.
Copy Download .nbib Format: NLM
Intravitreal Daptomycin for Recalcitrant Postoperative Endophthalmitis.

Case reports in ophthalmology

Sim JM, Kapoor KG, Wagner AL.
PMID: 27293409
Case Rep Ophthalmol. 2016 Feb 20;7(1):103-7. doi: 10.1159/000444046. eCollection 2016.

PURPOSE: To report the first case to our knowledge of intravitreal daptomycin used to successfully treat culture-negative vancomycin resistant to exogenous endophthalmitis.METHODS: Case report with preoperative, intraoperative, and postoperative findings.RESULTS: A 63-year-old Caucasian male underwent routine pars plana vitrectomy...

Cite
Sim JM, Kapoor KG, Wagner AL. Intravitreal Daptomycin for Recalcitrant Postoperative Endophthalmitis. Case Rep Ophthalmol. 2016;7(1):103-7doi: 10.1159/000444046.
Sim, J. M., Kapoor, K. G., & Wagner, A. L. (2016). Intravitreal Daptomycin for Recalcitrant Postoperative Endophthalmitis. Case reports in ophthalmology, 7(1), 103-7. https://doi.org/10.1159/000444046
Sim, Jennifer M, et al. "Intravitreal Daptomycin for Recalcitrant Postoperative Endophthalmitis." Case reports in ophthalmology vol. 7,1 (2016): 103-7. doi: https://doi.org/10.1159/000444046
Sim JM, Kapoor KG, Wagner AL. Intravitreal Daptomycin for Recalcitrant Postoperative Endophthalmitis. Case Rep Ophthalmol. 2016 Feb 20;7(1):103-7. doi: 10.1159/000444046. eCollection 2016. PMID: 27293409; PMCID: PMC4899650.
Copy Download .nbib Format: NLM
Acute Angioedema Triggered by Daptomycin.

Infectious diseases and therapy

Gisler V, Müller S, Müller L, Jörg-Walther L, Sendi P.
PMID: 27228997
Infect Dis Ther. 2016 Jun;5(2):201-5. doi: 10.1007/s40121-016-0111-4. Epub 2016 May 26.

INTRODUCTION: Daptomycin is a cyclic lipopeptide antibiotic, frequently administered for Staphylococcus aureus bloodstream infections. Numerous studies have shown that daptomycin is relatively safe and well tolerated. Serious adverse events possibly related to this antimicrobial compound are rare. We report...

Cite
Gisler V, Müller S, Müller L, et al. Acute Angioedema Triggered by Daptomycin. Infect Dis Ther. 2016;5(2):201-5doi: 10.1007/s40121-016-0111-4.
Gisler, V., Müller, S., Müller, L., Jörg-Walther, L., & Sendi, P. (2016). Acute Angioedema Triggered by Daptomycin. Infectious diseases and therapy, 5(2), 201-5. https://doi.org/10.1007/s40121-016-0111-4
Gisler, Valentin, et al. "Acute Angioedema Triggered by Daptomycin." Infectious diseases and therapy vol. 5,2 (2016): 201-5. doi: https://doi.org/10.1007/s40121-016-0111-4
Gisler V, Müller S, Müller L, Jörg-Walther L, Sendi P. Acute Angioedema Triggered by Daptomycin. Infect Dis Ther. 2016 Jun;5(2):201-5. doi: 10.1007/s40121-016-0111-4. Epub 2016 May 26. PMID: 27228997; PMCID: PMC4929090.
Copy Download .nbib Format: NLM
Draft Genome Sequences of Clinical Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strain APS211 and Its Daptomycin-Susceptible Progenitor APS210.

Genome announcements

Cameron DR, Jiang JH, Abbott IJ, Spelman DW, Peleg AY.
PMID: 26067951
Genome Announc. 2015 Jun 11;3(3). doi: 10.1128/genomeA.00568-15.

To assess the genetic factors contributing to daptomycin resistance in Staphylococcus aureus, the draft genome of a clinically derived daptomycin-nonsusceptible isolate APS211 was generated and compared to the draft sequence of its susceptible progenitor strain APS210. Four genetic differences...

Cite
Cameron DR, Jiang JH, Abbott IJ, et al. Draft Genome Sequences of Clinical Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strain APS211 and Its Daptomycin-Susceptible Progenitor APS210. Genome Announc. 2015;3(3)doi: 10.1128/genomeA.00568-15.
Cameron, D. R., Jiang, J. H., Abbott, I. J., Spelman, D. W., & Peleg, A. Y. (2015). Draft Genome Sequences of Clinical Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strain APS211 and Its Daptomycin-Susceptible Progenitor APS210. Genome announcements, 3(3), . https://doi.org/10.1128/genomeA.00568-15
Cameron, David R, et al. "Draft Genome Sequences of Clinical Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strain APS211 and Its Daptomycin-Susceptible Progenitor APS210." Genome announcements vol. 3,3 (2015). doi: https://doi.org/10.1128/genomeA.00568-15
Cameron DR, Jiang JH, Abbott IJ, Spelman DW, Peleg AY. Draft Genome Sequences of Clinical Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strain APS211 and Its Daptomycin-Susceptible Progenitor APS210. Genome Announc. 2015 Jun 11;3(3). doi: 10.1128/genomeA.00568-15. PMID: 26067951; PMCID: PMC4463516.
Copy Download .nbib Format: NLM
Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis.

Open forum infectious diseases

Johnson JA, Feeney ER, Kubiak DW, Corey GR.
PMID: 26677455
Open Forum Infect Dis. 2015 Oct 29;2(4):ofv156. doi: 10.1093/ofid/ofv156. eCollection 2015 Dec.

Oritavancin is a novel lipoglycopeptide with activity against Gram-positive organisms including streptococci, methicillin-resistant Staphylococcus aureus, vancomycin-resistant S aureus (VRSA), and vancomycin-resistant enterococci (VRE) [1-3]. The US Food and Drug Administration approved oritavancin as a single intravenous dose of 1200...

Cite
Johnson JA, Feeney ER, Kubiak DW, et al. Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis. Open Forum Infect Dis. 2015;2(4):ofv156doi: 10.1093/ofid/ofv156.
Johnson, J. A., Feeney, E. R., Kubiak, D. W., & Corey, G. R. (2015). Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis. Open forum infectious diseases, 2(4), ofv156. https://doi.org/10.1093/ofid/ofv156
Johnson, Jennifer A, et al. "Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis." Open forum infectious diseases vol. 2,4 (2015): ofv156. doi: https://doi.org/10.1093/ofid/ofv156
Johnson JA, Feeney ER, Kubiak DW, Corey GR. Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis. Open Forum Infect Dis. 2015 Oct 29;2(4):ofv156. doi: 10.1093/ofid/ofv156. eCollection 2015 Dec. PMID: 26677455; PMCID: PMC4677157.
Copy Download .nbib Format: NLM
Daptomycin for a complicated urinary tract infection with vancomycin-resistant Enterococcus faecium in a renal transplant recipient.

Clinical kidney journal

Eden G, Burkhardt O, Clajus C, Kielstein JT.
PMID: 25874096
Clin Kidney J. 2012 Aug;5(4):350-1. doi: 10.1093/ckj/sfs076.

There is an increasing prevalence of urinary tract infection (UTI) caused by multiresistant gram-negative enteric bacilli such as extended-spectrum beta-lactamase as well as Gram-positive enterococci whose vancomycin-resistance can be as high as 25%. We report on a 68-year-old Caucasian...

Cite
Eden G, Burkhardt O, Clajus C, et al. Daptomycin for a complicated urinary tract infection with vancomycin-resistant Enterococcus faecium in a renal transplant recipient. Clin Kidney J. 2012;5(4):350-1doi: 10.1093/ckj/sfs076.
Eden, G., Burkhardt, O., Clajus, C., & Kielstein, J. T. (2012). Daptomycin for a complicated urinary tract infection with vancomycin-resistant Enterococcus faecium in a renal transplant recipient. Clinical kidney journal, 5(4), 350-1. https://doi.org/10.1093/ckj/sfs076
Eden, Gabriele, et al. "Daptomycin for a complicated urinary tract infection with vancomycin-resistant Enterococcus faecium in a renal transplant recipient." Clinical kidney journal vol. 5,4 (2012): 350-1. doi: https://doi.org/10.1093/ckj/sfs076
Eden G, Burkhardt O, Clajus C, Kielstein JT. Daptomycin for a complicated urinary tract infection with vancomycin-resistant Enterococcus faecium in a renal transplant recipient. Clin Kidney J. 2012 Aug;5(4):350-1. doi: 10.1093/ckj/sfs076. PMID: 25874096; PMCID: PMC4393481.
Copy Download .nbib Format: NLM
Infusion-related reaction following daptomycin two-minute rapid intravenous administration.

Hospital pharmacy

Caulder CR, Sloan A, Yasir A, Bookstaver PB.
PMID: 25477584
Hosp Pharm. 2014 Jul;49(7):644-6. doi: 10.1310/hpj4907-644.

BACKGROUND: Erythroderma, or red man's syndrome, is a common infusion-related reaction following vancomycin administration. Erythroderma following daptomycin rapid infusion has not been documented.OBJECTIVE: To report a case of erythroderma following daptomycin 2-minute intravenous (IV) injection.CASE REPORT: A review of...

Cite
Caulder CR, Sloan A, Yasir A, et al. Infusion-related reaction following daptomycin two-minute rapid intravenous administration. Hosp Pharm. 2014;49(7):644-6doi: 10.1310/hpj4907-644.
Caulder, C. R., Sloan, A., Yasir, A., & Bookstaver, P. B. (2014). Infusion-related reaction following daptomycin two-minute rapid intravenous administration. Hospital pharmacy, 49(7), 644-6. https://doi.org/10.1310/hpj4907-644
Caulder, Celeste R, et al. "Infusion-related reaction following daptomycin two-minute rapid intravenous administration." Hospital pharmacy vol. 49,7 (2014): 644-6. doi: https://doi.org/10.1310/hpj4907-644
Caulder CR, Sloan A, Yasir A, Bookstaver PB. Infusion-related reaction following daptomycin two-minute rapid intravenous administration. Hosp Pharm. 2014 Jul;49(7):644-6. doi: 10.1310/hpj4907-644. PMID: 25477584; PMCID: PMC4252235.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 421 entries